About this trial
This randomized controlled trial aims to evaluate whether combining blood flow restriction training (BFRT) with repetitive transcranial magnetic stimulation (rTMS) improves limb function in stroke patients with hemiplegia. A total of 69 participants will be randomly assigned to three groups: conventional rehabilitation alone (control group), conventional rehabilitation plus rTMS, or conventional rehabilitation plus BFRT combined with rTMS. The intervention period is 4 weeks, with assessments conducted at baseline and at the end of treatment. The primary outcome is the change in upper extremity Fugl-Meyer Assessment (FMA-UE) score, which measures motor function recovery. Secondary outcomes include Wolf Motor Function Test, Modified Barthel Index for daily activities, Berg Balance Scale, and safety parameters such as coagulation markers and adverse events. This study will help determine whether this combined approach offers a more effective rehabilitation strategy for stroke survivors.
Eligibility criteria
Qualifiers
Diagnosis of stroke (ischemic or hemorrhagic) confirmed by CT or MRI, meeting the diagnostic criteria of the 4th National Cerebrovascular Disease Conference
First-ever stroke or recurrent stroke without residual dysfunction from prior events
Age 25-70 years, male or female
Stable vital signs, conscious, able to understand and follow therapist instructions
Disqualifiers
Presence of cardiac pacemaker or other metal implants
Deafness, severe cognitive impairment, history of psychiatric disorders
Shoulder subluxation
Extensive skin damage on affected limbs
Trial design
Treatments tested in this trial
- Conventional Rehabilitation
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- Blood Flow Restriction Training (BFRT)